Chemplast Sanmar IPO Basis of Allotment

Our Company was originally incorporated on March 13,1985 as Urethanes India United ('UIL') under the provisions of Companies Act, 1956, at Chennai, pursuant to a certificate of incorporation dated March 13, 1985 issued by the Registrar of Companies. Tamil Nadu at Chennai ("RoC") and commenced operations pursuant to a certificate for commencement of business dated April 2, 1985, issued by the RoC. Subsequently, Chemicals and Plastics India Limited ("CPIL"), was amalgamated with UIL pursuant to the CPIL Scheme of Amalgamation (as defined hereinafter) effective October 1, 1991. Thereafter, pursuant to the CPIL Scheme of Amalgamation, a resolution of our Board dated March 10, 1992, and a resolution of our Shareholders dated March 31, 1992, our name was changed from 'Urethanes India Limited' to 'Chemicals and Plastics India Limited' and a fresh certificate of incorporation was issued upon a change of name by the RoC on May 15, 1992. Subsequently, pursuant to a resolution of our Board dated June 27, 1995 and a resolution of our Shareholders dated September 1, 1995, our name was changed from "Chemicals and Plastics India Limited" to 'Chemplast Sanmar Limited" and a fresh certificate of incorporation was issued upon a change of name by the RoC on September 28, 1995. For further details in relation to change in name and Registered Office of our Company, see 'History and Certain Corporate Matters' on page 162 of the Prospectus dated August 13, 2021 ('Prospectus').

Our Company has filed the Prospectus dated August 13, 2021 with the RoC and the Equity Shares are proposed to be listed on the National Stock Exchange of India Limited ("NSE") and the BSE Limited and the trading will commence from August 24, 2021.

INITIAL PUBLIC OFFERING OF UP TO 71,164,509 EQUITY SHARES OF FACE VALUE OF RS. 5 EACH ("EQUITY SHARES") OF CHEMPLAST SANMAR LIMITED (THE "COMPANY" OR THE "ISSUER") FOR CASH AT A PRICE OF RS. 541 PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF Rs. 536 PER EQUITY SHARE) ("OFFER PRICE") AGGREGATING TO RS. 38,500 MILLION (THE "OFFER") COMPRISING A FRESH ISSUE OF 24,029,574 EQUITY SHARES AGGREGATING TO RS. 13,000 MILLION BY OUR COMPANY (THE "FRESH ISSUE") AND AN OFFER FOR SALE OF 47,134,935 EQUITY SHARES AGGREGATING TO Rs. 25,500 MILLION, COMPRISING AN OFFER FOR SALE OF 45,534,935 EQUITY SHARES AGGREGATING TO RS. 24,634.40 MILLION BY SANMAR HOLDINGS LIMITED ("SHL" OR THE "PROMOTER SELLING SHAREHOLDER"), AND 1,600,000 EQUITY SHARES AGGREGATING TO RS. 865.60 MILLION BY SANMAR ENGINEERING SERVICES LIMITED ("SESL" OR THE "PROMOTER GROUP SELLING SHAREHOLDER", AND TOGETHER WITH THE PROMOTER SELLING SHAREHOLDER REFERRED TO AS "SELLING SHAREHOLDERS" AND SUCH OFFER FOR SALE BY THE SELLING SHAREHOLDERS, THE "OFFER FOR SALE"). THE OFFER WOULD CONSTITUTE 45.01% OF OUR POST-OFFER PAID-UP EQUITY SHARE CAPITAL.

*NA since networth is negative.

# UPI Mandate end time and date was 12:00 p.m. on August 13, 2021

This Offer was made in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended ("SCRR"), read with Regulation 31 of the SEBIICDR Regulations. The Offer was made through the Book Building Process in terms of Regulation 6(2) of the SEBI ICDR Regulations, wherein not less than 75% of the Offer was available for allocation on a proportionate basis to Qualified Institutional Buyers (QIBs) (the "QIB Portion"), provided that our Company and the Selling Shareholders in consultation with the GCBRLMs and BRLMs allocated up to 60% of the QIB Portion to Anchor Investors on a discretionary basis, ("Anchor Investor Portion") out of which one-third was reserved for domestic Mutual Funds, subject to valid Bids having been received from domestic Mutual Funds at or above the Anchor Investor Allocation Price, in accordance with the SEBI ICDR Regulations. Further, 5% of the Net QIB Portion was made available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the QIB Portion was made available for allocation on a proportionate basis to all QIB Bidders (other than Anchor Investors), including Mutual Funds, subject to valid Bids being received at or above the Offer Price. If at least 75% of the Offer could not be Allotted to QIBs. the Bid Amounts received by our Company would be required to be refunded. Further, not more than 15% of the Offer was available for allocation on a proportionate basis to Non-Institutional Bidders and not more than 10% of the Offer was available for allocation to Retail Individual Bidders ("RIBs") in accordance with the SEBI ICDR Regulations, subject to valid Bids being received from them at or above the Offer Price. All potential Bidders (except Anchor Investors) were mandatory required to utilise the Application Supported by Blocked Amount ("ASBA") process by providing details of their respective ASBA accounts and UPI ID in case of RIBs using the UPI Mechanism, as applicable, pursuant to which their corresponding Bid Amount was blocked by the Self Certified Syndicate Banks (SCSBs) or by the Sponsor Bank under the UPI Mechanism, as the case may be. to the extent of the respective Bid Amounts. Anchor Investors were not permitted to participate in the Offer through the ASBA Process. For further details, see 'Offer Procedure' on page 483 of the Prospectus.

The bidding for Anchor Investor opened and dosed on August 09, 2021. The company received 78 applications from 50 anchor investors for 33,111,531 Equity Shares. The Anchor investor price was finalized at Rs. 541 per Equity Share. A total of 32,024,029 Equity Shares were allocated under the Anchor Investor Portion aggregating to Rs. 17,324,999,689.

The Offer received 353,246 applications for 114,827,301 Equity Shares (prior to technical rejections) resulting in 1.61 times subscription. The details of the applications received in the Offer from various categories are as under: (before technical rejections):

Final Demand

A summary of the final demand as at different Bid prices is as under:

The Basis of Allotment was finalized in consultation with the Designated Stock Exchange, being the NSE on August 18, 2021.

A. Allotment to Retail Individual Bidders (after technical rejections) (including ASBA Applications)

The Basis of Allotment to the Retail Individual Bidders, who have bid at the Cut-Off Price or at the Offer Price of Rs. 541 per Equity Share, was finalized in consultation with the NSE This category has been subscribed to the extent of 1.64307 times. The total number of Equity Shares Allotted in Retail Portion is 7,116,450 Equity Shares to 263,572 successful Retail Individual Bidder. The category-wise details of the Basis of Allotment are as under:

Please Note: 1 additional Share shall be allotted to 6 Allottee from amongst 24429 Successful Applicants from the categories 54-351 (i.e. Excluding successful applicants from Category 27) in the ratio of 6:24429

B. Allotment to Non-Institutional Bidders (After Technical Rejections)

The Basis of Allotment to the Non-Institutional Bidders, who have bid at the Offer Price of Rs. 541 per Equity Share or above, was finalized in consultation with the NSE. The Non-Institutional Portion has been subscribed to the extent of 1.02474 times The total number of Equity Shares Allotted in this category is 10,674,676 Equity Shares to 698 successful Non- Institutional Bidder. The category-wise details of the Basis of Allotment are as under: (sample)

C. Allotment to QIBs (excluding Anchor Investors) (After Technical Rejections)

Allotment to QIBs, who have Bid at the Offer Price of Rs. 541 per Equity Share or above, has been done on a proportionate basis in consultation with the NSE. This category has been subscribed to the extent of 2.74827 times of QIB Portion. As per the SEBIICDR Regulations, Mutual Funds were Allotted 5% of the Equity Shares of QIB Portion available i.e. 1,067,468 Equity Shares and other QIBs and unsatisfied demand of Mutual Funds were Allotted the remaining available Equity Shares i.e. 20,281,886 Equity Shares on a proportionate basis. The total number of Equity Shares Allotted in the QIB Portion is 21,349,354 Equity Shares, which were allotted to 38 successful QIB Bidders. The category-wise details of the Basis of Allotment are as under:

D. Allotment to Anchor Investors

The Company and the Selling Shareholders, in consultation with the GCBRLMs and BRLMs, have allocated 32,024,029 Equity Shares to 50 Anchor Investors (through 78 Applications) at the Anchor Investor Offer Price of Rs. 541 per Equity Share in accordance with the SEBIICDR Regulations. This represents 60% of the QIB Portion.

The IPO Committee of our Company on August 18, 2021 has taken on record the Basis of Allotment of Equity Shares approved by the Designated Stock Exchange, being NSE and has allotted the Equity Shares to various successful Bidders. The Allotment Advice-cum- Intimations and/ or notices will be dispatched to the address of the investors as registered with the depositories. Further, the instructions to the Self Certified Syndicate Banks for unblocking of funds, transfer to Public Offer Account have been issued on August 18, 2021 and payment to non-Syndicate brokers have been issued on August 19, 2021. In case the same is not received within ten days, investors may contact the Registrar to the Offer at the address given below. The Equity Shares Allotted to the successful Allottees have been uploaded on August 20, 2021 for credit into the respective beneficiary accounts subject to validation of the account details with the depositores concerned. The Company has filed the Listing application with NSE and BSE on August 19, 2021. The Company has received listing and trading approval from NSE and BSE and the trading will commence on August 24, 2021.

All capitalised terms used and not specifically defined herein shall have the same meaning as ascribed to them in the Prospectus

CORRIGENDUM - NOTICE TO INVESTORS

This corrigendum is with reference to the Prospectus filed in related to the Offer. In this regard please note the following

Under the section "Offer Structure" on page 480 of the Prospectus, under "Particulars - Number of Equity Shares available for Allotment/ allocation" for the "Non-Institutional Bidders' should be read as " 1,06,74,676" instead of "1,06,74,677".

All capitalized terms used in this Corrigendum shall, unless the context otherwise requires, have the meaning ascribed in the Prospectus. The Prospectus should be read in conjunction with this Corrigendum. The Prospectus stands amended to the extent stated hereinabove.

INVESTORS PLEASE NOTE

The details of the allotment made will be hosted on the website of the Registrar to the Offer, KFin Technologies Private Limited at www.kfintech.com

All future correspondence in this regard may kindly be addressed to the Registrar to the Offer quoting full name of the first/ sole Bidder. Bid cum Application Form number. Bidder DP ID, Client ID, PAN, date of submission of Bid cum Application Form, address of the Bidder, number of Equity Shares applied for, the name and address of the Designated Intermediary where the Bid cum Application Form was submitted by the Bidder and a copy of the Acknowledgment Slip received from the Designated Intermediary at the address given below:

	KFin Technologies Private Limited
	Selenium, Tower B, Plot No- 31 and 32, Financial District, Nanakramguda, Serilingampally,
	Hyderabad, Rangareddi - 500 032, Telangana, India
	Tel +(91)40 6716 2222, E-mail: chemplast.ipo@kfintech.com
	Investor grievance e-mail: einward.ris@kfintech.com
	Website www.kfintech.com
	Contact Person: M Murali Krishna; SEBl Registration No.: INR000000221

For Issue related grievance investors may contact: ICICI Securities limited, Shekhar Asnani/Knstina Dias, Tel: +(91) 22 2288 2460. E-mail: chemplast.sanmar@icicisecurities.com ; Axis Capital limited, Sagar Jataklya Tel: +(91) 22 4325 2183. E-mail: chemplastipo@axiscap.in . Credit Suisse Securities (India) Private Limited, Abhishek Joshi, Tel: +91 22 6777 3885, E-mail: list.chemplastsanmaripo@creditsuisse.com : IIFL Securities Limited, Vishal Bangard /Aditya Agarwal, Tel: +(91) 22 4646 4600, E-mail: csl.ipo@iiflcap.com; Ambit Private Limited, Nikhil Bhiwapurkar/ Miraj Sampat, Tel: + 91 22 6623 3000, E-mail: csl.ipo@ambit.co : BOB Capital Markets Limited, Ninad Jape/Arpita Maheshwari. Tel . +(91) 22 6138 9300, E-mail csl.ipo@bobcaps.in; HDFC Bank Limited, Harsh Thakkar / Ravi Sharma Tel: +(91) 22 3395 8233, E-mail sanmaripo@hdfcbank.com ; Induslnd Bank Limited, Priyankar Shetty, Tel: +(91) 22 7143 2206, E-mail: cslipo@indusind.com ; YES Securities (India) Limited, Sachin Kapoor/ Nidhi Gupta, Tel: +(91) 22 6507 8131, E-mail: chemplast.ipo@ysil.in. For UPI related queries, investors can contact NPCI at the toll free number: 18001201740 and Mail Id: ipo.upi@npci.org .in; ICICI Bank Limited at Tel: + 91 22 6681 8911/23/24 and Email: kmr.saurabh@icicibank.com , and the Registrar to the Offer at Tel. +(91) 40 6716 2222, E-mail chemplast.ipo@kfintech.com

THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF CHEMPLAST SANMAR LIMITED.

CHEMPLAST SANMAR LIMITED has filed the Prospectus with RoC on August 14, 2021 and thereafter with SEBI and Stock Exchanges. The Prospectus is available on the on the website of SEBI at www.sebi.gov.in, websites of the Stock Exchanges i.e. BSE Limited and National Stock Exchange of India Limited at www.bseindia.com and www.nseindia.com, respectively, and is available on the websites of the GCBRLMs. i.e. ICICI Securities Limited, Axis Capital Limited, Credit Suisse Securities (India) Private Limited, IIFL Securities Limited, Ambit Private Limited, BOB Capital Markets Limited and HDFC Bank Limited at www.icicisecurities.com, www.axiscapital.co.in. https//www.credit-suisse.com/in/en/investment-banking-in-india/ipo.html , www.iiflcap.com, www.ambit.co, www.bobcaps.in and www.hdfcbank.com, respectively and the websites of the BRLMs. i.e. Induslnd Bank Limited and YES Securities (India) Limited at www.indusind.com and www.yesinvest.in , respectively. Investors should note that investment in equity shares involves a high degree of risk and for details relating to such risk, please see the section entitled "Risk Factors'"on page 32 of the Prospectus. The Equity Shares offered in the Offer have not been and will not be registered under the U.S. Securities Act of 1933, as amended (^"U.S. Securities Act"), or any other applicant from, or in a transaction not subject to the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. Accordingly, the Equity Shares are being applicable law of the United States and, unless so registered, may not be offered or sold within the United States, except pursuant to an exemption 144A under the U S. Securities Act) pursuant to Section 4(a) of the U.S. Securities Act. and (ii) outside the United States in "offshore transactions" in reliance on Regulations are being offered and sold (i) within the United States only to persons reasonably believed to be 'qualified institutional buyers' (as defined in Rule public offering of the Equity Shares in the United States ion S under the U.S Securities Act and pursuant to the applicable laws of the jurisdiction where those offers and sales are made. There will be no public offering of the Equity Shares in the United States